Organization
Ivy Brain Tumor Center
1 clinical trial
4 abstracts
Abstract
WITHDRAWN: A phase 0/1b study of AZD1390 plus radiotherapy in patients with recurrent glioblastoma.Org: Barrow Neurological Institute, Ivy Brain Tumor Center,
Abstract
Niraparib efficacy in patients with newly-diagnosed glioblastoma: Clinical readout of a phase 0/2 "trigger" trial.Org: Ivy Brain Tumor Center at Barrow Neurological Institute, Ivy Brain Tumor Center,
Clinical trial
A Phase 3, Open-label, Randomized 2-arm Study Comparing the Clinical Efficacy and Safety of Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated GlioblastomaStatus: Not yet recruiting, Estimated PCD: 2027-12-01
Abstract
A phase 0/2 trigger trial of niraparib in patients with newly diagnosed glioblastoma.Org: Ivy Brain Tumor Center, Phoenix, AZ,
Abstract
A phase 0 pharmacokinetic trigger trial of infigratinib in patients with recurrent high-grade glioma.Org: Ivy Brain Tumor Center, Barrow Neurological Institute,